These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23861803)

  • 21. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
    Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
    Zhang C; Steiner JP; Hamilton GS; Hicks TP; Poulter MO
    J Neurosci; 2001 Aug; 21(15):RC156. PubMed ID: 11459877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
    Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
    Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
    Ayadi AE; Zigmond MJ; Smith AD
    Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.
    Anastasía A; Torre L; de Erausquin GA; Mascó DH
    J Neurochem; 2009 May; 109(3):755-65. PubMed ID: 19245661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease.
    Sullivan AM; Opacka-Juffry J; Hötten G; Pohl J; Blunt SB
    Neurosci Lett; 1997 Sep; 233(2-3):73-6. PubMed ID: 9350835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental change on dopaminergic neurons in striatum of Parkinson disease rats.
    Chen XY; Li J; Qi WQ; Shen SH
    Histol Histopathol; 2007 Oct; 22(10):1085-90. PubMed ID: 17616935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
    El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1998 Jan; 82(1):129-37. PubMed ID: 9483509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.
    Gonçalves VC; Pinheiro DJLL; de la Rosa T; de Almeida AG; Scorza FA; Scorza CA
    Nutrients; 2020 May; 12(6):. PubMed ID: 32466610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J; Sharma MK; Gengler S; Hölscher C
    Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
    Andersson M; Konradi C; Cenci MA
    J Neurosci; 2001 Dec; 21(24):9930-43. PubMed ID: 11739600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.